Skip to main content
REVB
NASDAQ Life Sciences

Q3 Net Loss Widens to $3.3M as Cash Falls to $9.1M; Runway Into Q2 2027

Tom Rudovsky · Reported by BusinessWire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$3.56
Mkt Cap
$2.026M
52W Low
$3.08
52W High
$40.6
52W Position info
16% above low
Off High info
91% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

REVB sits 16% above its 52-week low of $3.08.

Summary

Revelation's third-quarter net loss widened to $3.3 million from $1.9 million a year earlier, with Q3 EPS of -5.92, and the nine-month loss reached $9.6 million versus $6.4 million. Cash fell to $9.1 million at September 30 from $10.7 million at year-end 2025, and management says that funds operations only into the second quarter of 2027. Operating cash burn accelerated to $2.6 million in the quarter from $1.6 million a year ago, with R&D spending up to $4.8 million for nine months from $3.1 million. The release also notes a $94 billion total addressable market assessment for Gemini and the selection of a global CRO for the upcoming acute kidney injury study. This follows the 10-Q filed minutes earlier and comes two weeks after the 1-for-7 reverse split took effect on October 20, 2026. The company is a clinical-stage story with no revenue, so the runway into Q2 2027 is the number that matters — any AKI study start will need cash before then.

At the time of this announcement, REVB was trading at $3.56 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2M. The 52-week trading range was $3.08 to $40.60. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

REVB - Latest Insights

REVB
Nov 05, 2026, 5:23 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $3.56
Real-time Price: $4.51 info
Change: +$0.950 (+27%) info
Market Cap: $2.026M info
REVB
Oct 16, 2026, 9:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.7622
Real-time Price: $4.51 info
Change: Reverse Stock Split info
Market Cap: $2.026M info
REVB
Aug 06, 2026, 4:19 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.12
Real-time Price: $4.51 info
Change: Reverse Stock Split info
Market Cap: $2.026M info
REVB
Aug 06, 2026, 4:07 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.12
Real-time Price: $4.51 info
Change: Reverse Stock Split info
Market Cap: $2.026M info
REVB
Jul 13, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.9869
Real-time Price: $4.51 info
Change: Reverse Stock Split info
Market Cap: $2.026M info